Tissue Heart Valves - Medical Devices Pipeline Assessment, 2017

  • ID: 4394482
  • Report
  • 118 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Abbott Vascular Inc
  • CryoLife Inc
  • Edwards Lifesciences Corp
  • Revivicor Inc
  • Tissue Regenix Ltd
  • University of Minnesota
  • MORE
Tissue Heart Valves - Medical Devices Pipeline Assessment, 2017

Summary

The Medical Devices sector report, “Tissue Heart Valves - Medical Devices Pipeline Assessment, 2017" provides an overview of Tissue Heart Valves currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Tissue Heart Valves pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Tissue Heart Valves under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Tissue Heart Valves and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry
Reasons to buy

The report enables you to:
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Tissue Heart Valves under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Vascular Inc
  • CryoLife Inc
  • Edwards Lifesciences Corp
  • Revivicor Inc
  • Tissue Regenix Ltd
  • University of Minnesota
  • MORE
1 Table of Contents
2 Introduction
2.1 Tissue Heart Valves Overview
3 Products under Development
3.1 Tissue Heart Valves - Pipeline Products by Stage of Development
3.2 Tissue Heart Valves - Pipeline Products by Segment
3.3 Tissue Heart Valves - Pipeline Products by Territory
3.4 Tissue Heart Valves - Pipeline Products by Regulatory Path
3.5 Tissue Heart Valves - Pipeline Products by Estimated Approval Date
3.6 Tissue Heart Valves - Ongoing Clinical Trials
4 Tissue Heart Valves - Pipeline Products under Development by Companies
4.1 Tissue Heart Valves Companies - Pipeline Products by Stage of Development
4.2 Tissue Heart Valves - Pipeline Products by Stage of Development
5 Tissue Heart Valves Companies and Product Overview
5.1 Abbott Vascular Inc Company Overview
5.1.1 Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 Children's Hospital Boston Company Overview
5.2.1 Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview
5.3 Colibri Heart Valve, LLC Company Overview
5.3.1 Colibri Heart Valve, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.4 CorMatrix Cardiovascular Inc Company Overview
5.4.1 CorMatrix Cardiovascular Inc Pipeline Products & Ongoing Clinical Trials Overview
5.5 CryoLife Inc Company Overview
5.5.1 CryoLife Inc Pipeline Products & Ongoing Clinical Trials Overview
5.6 Cytograft Tissue Engineering Inc (Inactive) Company Overview
5.6.1 Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.7 Daidalos Solutions BV Company Overview
5.7.1 Daidalos Solutions BV Pipeline Products & Ongoing Clinical Trials Overview
5.8 Edwards Lifesciences Corp Company Overview
5.8.1 Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview
5.9 Medtronic plc Company Overview
5.9.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
5.10 Revivicor Inc Company Overview
5.10.1 Revivicor Inc Pipeline Products & Ongoing Clinical Trials Overview
5.11 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
5.11.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview
5.12 Stellenbosch University Company Overview
5.12.1 Stellenbosch University Pipeline Products & Ongoing Clinical Trials Overview
5.13 Tissue Regenix Ltd Company Overview
5.13.1 Tissue Regenix Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.14 University of California Irvine Company Overview
5.14.1 University of California Irvine Pipeline Products & Ongoing Clinical Trials Overview
5.15 University of Cambridge Company Overview
5.15.1 University of Cambridge Pipeline Products & Ongoing Clinical Trials Overview
5.16 University of Minnesota Company Overview
5.16.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview
5.17 ValveXchange, Inc. (Inactive) Company Overview
5.17.1 ValveXchange, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.18 VueKlar Cardiovascular Ltd Company Overview
5.18.1 VueKlar Cardiovascular Ltd Pipeline Products & Ongoing Clinical Trials Overview
6 Tissue Heart Valves- Recent Developments
6.1 Aug 23, 2017: OmniGuide Appoints Ajay Bhave as its Chief Technology Officer
6.2 Aug 22, 2017: Medtronic Reports First Quarter Financial Results
6.3 Aug 09, 2017: LivaNova Reports Second Quarter 2017 Results
6.4 Aug 04, 2017: LivaNovas Perceval Sutureless Aortic Heart Valve Awarded New Technology Add-on Payment from the Center for Medicare and Medicaid Services
6.5 Aug 02, 2017: Medtronic Expands Heart Valve Portfolio with FDA Approval and CE Mark of the Avalus Surgical Aortic Valve
6.6 Jul 24, 2017: CryoLife Reports Second Quarter 2017 Financial Results
6.7 Jul 05, 2017: Edward's INSPIRIS RESILIA Valve Receives FDA Approval
6.8 Jun 12, 2017: LivaNova Appoints Keyna Skeffington as Senior Vice President and General Counsel
6.9 May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results
6.10 May 16, 2017: LivaNova Announces Thad Huston as Chief Financial Officer
6.11 May 04, 2017: LivaNova Announces New Data Reaffirming Value of Perceval for Aortic Valve Replacement in Aortic Stenosis Patients
6.12 May 03, 2017: LivaNova Reports First Quarter 2017 Results
6.13 Apr 28, 2017: LivaNova to Unveil New Data Further Demonstrating the Perceval Sutureless Valve is a Safe and Effective Aortic Valve Replacement for Patients
6.14 Apr 26, 2017: CryoLife Reports First Quarter 2017 Financial Results
6.15 Apr 25, 2017: Edwards Lifesciences Reports First Quarter Results
6.16 Mar 31, 2017: LivaNova Announces Chief Financial Officer Resignation
6.17 Mar 31, 2017: LivaNova Reiterates Full-Year 2017 Guidance
6.18 Mar 14, 2017: Medtronic Melody Transcatheter Pulmonary Valve First of Its Kind to Receive FDA Approval for Implantation in Failed Surgical Pulmonary Heart Valves
6.19 Mar 01, 2017: LivaNova Reports Fourth Quarter and Full-Year 2016 Results
6.20 Feb 23, 2017: LivaNova Announces Its Intent to Delist from London Stock Exchange
6.21 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results
6.22 Feb 15, 2017: CryoLife Reports Fourth Quarter and Full Year 2016 Financial Results
6.23 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors
6.24 Feb 01, 2017: Edwards Lifesciences Reports Fourth Quarter Results
6.25 Jan 27, 2017: New Data Reinforce the Clinical Value of the Perceval Sutureless Valve as a Safe and Effective Bioprosthesis for Patients in Need of Aortic Valve Replacement
6.26 Dec 08, 2016: Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference
6.27 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results
6.28 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report
6.29 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction
6.30 Nov 02, 2016: LivaNova Announces CEO Transition: Damien McDonald to Succeed Andre-Michel Ballester
6.31 Nov 02, 2016: LivaNova Reports Third Quarter 2016 Results
6.32 Nov 01, 2016: Early And Sustained Quality Of Life Improvements Seen For Intermediate Risk Patients Treated With Edwards Transcatheter Valves
6.33 Oct 31, 2016: EDWARDS INTUITY Elite Rapid Deployment Valve Approved In Canada
6.34 Oct 26, 2016: CryoLife Reports Third Quarter 2016 Financial Results
6.35 Oct 25, 2016: James W. Bullock Joins CryoLife Board of Directors
6.36 Oct 25, 2016: Edwards Lifesciences Reports Third Quarter Results
6.37 Oct 19, 2016: St. Jude Medical Reports Third Quarter 2016 Results
6.38 Oct 03, 2016: Medtronic Avalus Surgical Aortic Valve Shows Positive Outcomes in One-Year Clinical Trial Results
6.39 Sep 29, 2016: Edwards INSPIRIS RESILIA Valve Receives CE Mark
6.40 Sep 29, 2016: LivaNova Announces Half-Year Financial Report
6.41 Sep 28, 2016: Northwestern Medicine First in Illinois to Implant New FDA-Approved Aortic Valve
6.42 Sep 27, 2016: Artificial Blood Vessels Developed in the Lab can Grow with the Recipient
6.43 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services
7 Appendix
7.1 Methodology
7.2 About
7.3 Contact
7.4 Disclaimer

List of Tables
Table 1: Tissue Heart Valves - Pipeline Products by Stage of Development
Table 2: Tissue Heart Valves - Pipeline Products by Segment
Table 3: Tissue Heart Valves - Pipeline Products by Territory
Table 4: Tissue Heart Valves - Pipeline Products by Regulatory Path
Table 5: Tissue Heart Valves - Pipeline Products by Estimated Approval Date
Table 6: Tissue Heart Valves - Ongoing Clinical Trials
Table 7: Tissue Heart Valves Companies - Pipeline Products by Stage of Development
Table 8: Tissue Heart Valves - Pipeline Products by Stage of Development
Table 9: Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Tendyne Bioprosthetic Mitral Valve Implantation System - Product Status
Table 11: Tendyne Bioprosthetic Mitral Valve Implantation System - Product Description
Table 12: Abbott Vascular Inc - Ongoing Clinical Trials Overview
Table 13: Tendyne Bioprosthetic Mitral Valve Implantation System - Early Feasibility Study of the Tendyne Mitral Valve System
Table 14: Tendyne Bioprosthetic Mitral Valve Implantation System - Safety and Performance of the Tendyne Transcatheter Mitral Valve Implantation system (TMVI) in Inoperable Subjects with Mitral Regurgitation (MR)
Table 15: Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview
Table 16: Heart Valve Leaflet - Product Status
Table 17: Heart Valve Leaflet - Product Description
Table 18: Colibri Heart Valve, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 19: Pulmonary Valve - Product Status
Table 20: Pulmonary Valve - Product Description
Table 21: Sutureless Surgical Aortic Valve - Product Status
Table 22: Sutureless Surgical Aortic Valve - Product Description
Table 23: CorMatrix Cardiovascular Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 24: CorMatrix ECM - Heart Valve Repair - Product Status
Table 25: CorMatrix ECM - Heart Valve Repair - Product Description
Table 26: CorMatrix ECM - Heart Valve Replacement - Product Status
Table 27: CorMatrix ECM - Heart Valve Replacement - Product Description
Table 28: CorMatrix ECM Tricuspid Heart Valve - Product Status
Table 29: CorMatrix ECM Tricuspid Heart Valve - Product Description
Table 30: CorMatrix Cardiovascular Inc - Ongoing Clinical Trials Overview
Table 31: CorMatrix ECM - Heart Valve Repair - Cardial Infarct Repair Using CorMatrix-ECM: Clinical Feasibility Study
Table 32: CorMatrix ECM Tricuspid Heart Valve - CorMatrix ECM Tricuspid Valve Replacement Safety and Early Feasibility
Table 33: CryoLife Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 34: CryoValve SGAV - Product Status
Table 35: CryoValve SGAV - Product Description
Table 36: Synergraft Xenograft Heart Valve - Product Status
Table 37: Synergraft Xenograft Heart Valve - Product Description
Table 38: Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 39: Cytograft Valve - Product Status
Table 40: Cytograft Valve - Product Description
Table 41: Daidalos Solutions BV Pipeline Products & Ongoing Clinical Trials Overview
Table 42: Sutureless Aortic valve Prosthesis - Product Status
Table 43: Sutureless Aortic valve Prosthesis - Product Description
Table 44: Sutureless Mitral Valve Prostheses - Product Status
Table 45: Sutureless Mitral Valve Prostheses - Product Description
Table 46: Sutureless Tricuspid Valve Prostheses - Product Status
Table 47: Sutureless Tricuspid Valve Prostheses - Product Description
Table 48: Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 49: GLX Aortic Conduit - Product Status
Table 50: GLX Aortic Conduit - Product Description
Table 51: INSPIRIS RESILIA Aortic Valve - Product Status
Table 52: INSPIRIS RESILIA Aortic Valve - Product Description
Table 53: INTUITY Valve System - Product Status
Table 54: INTUITY Valve System - Product Description
Table 55: KONECT Conduit - Product Status
Table 56: KONECT Conduit - Product Description
Table 57: Magna EASE Surgical Valve With GLX - Product Status
Table 58: Magna EASE Surgical Valve With GLX - Product Description
Table 59: Edwards Lifesciences Corp - Ongoing Clinical Trials Overview
Table 60: INTUITY Valve System - A Randomized Comparison of the EDWARDS INTUITY Valve System and Commercially Available Aortic Bioprostheses in Subjects Undergoing Surgical Aortic Valve Replacement
Table 61: INTUITY Valve System - Multi-center Experience with the Rapid Deployment Edwards INTUITY Valve System for Aortic Valve Replacement
Table 62: INTUITY Valve System - Surgical Treatment of Aortic Stenosis with a Next Generation Surgical Aortic Valve
Table 63: Magna EASE Surgical Valve With GLX - Clinical Study to Evaluate the Performance of Magna Ease Heart Valve in Chinese Patients
Table 64: Magna EASE Surgical Valve With GLX - Edwards Receives IDE for U.S. Clinical Trial of New Heart Valve Tissue Treatment Platform
Table 65: INSPIRIS RESILIA Aortic Valve - Prospective, Non-randomized, Multicenter Clinical Evaluation of the Edwards Pericardial Aortic and Mitral Bioprostheses (Models 11000a and 11000m) with a New Tissue Treatment Platform: COMMENCE
Table 66: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
Table 67: Avalus Surgical Aortic Valve - Product Status
Table 68: Avalus Surgical Aortic Valve - Product Description
Table 69: Closed-Chest Aortic Tissue Valve - Product Status
Table 70: Closed-Chest Aortic Tissue Valve - Product Description
Table 71: Enable Valve-Beating Heart Procedure - Product Status
Table 72: Enable Valve-Beating Heart Procedure - Product Description
Table 73: Medtronic plc - Ongoing Clinical Trials Overview
Table 74: Avalus Surgical Aortic Valve - Medtronic Pericardial Surgical Aortic Valve Replacement Pivotal Trial a Multi-center, Non-randomized Trial to Determine the Safety and Effectiveness of the Model 400 Aortic Valve Bioprosthesis in Patients with Aortic Valve Disease
Table 75: Revivicor Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 76: Heart Valve - Product Status
Table 77: Heart Valve - Product Description
Table 78: Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview
Table 79: Tissue Based Cardiac Valve - Product Status
Table 80: Tissue Based Cardiac Valve - Product Description
Table 81: Stellenbosch University Pipeline Products & Ongoing Clinical Trials Overview
Table 82: Percutaneous Heart Valve - Product Status
Table 83: Percutaneous Heart Valve - Product Description
Table 84: Tissue Regenix Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 85: Cardiopure - Aortic Heart Valve - Product Status
Table 86: Cardiopure - Aortic Heart Valve - Product Description
Table 87: Cardiopure - Pulmonary Heart Valve - Product Status
Table 88: Cardiopure - Pulmonary Heart Valve - Product Description
Table 89: CardioPure HV - Product Status
Table 90: CardioPure HV - Product Description
Table 91: University of California Irvine Pipeline Products & Ongoing Clinical Trials Overview
Table 92: Bileaflet Bioprosthetic Mitral Valve - Product Status
Table 93: Bileaflet Bioprosthetic Mitral Valve - Product Description
Table 94: Heart Valve Leaflets - Product Status
Table 95: Heart Valve Leaflets - Product Description
Table 96: University of Cambridge Pipeline Products & Ongoing Clinical Trials Overview
Table 97: Polymeric Heart Valve - Product Status
Table 98: Polymeric Heart Valve - Product Description
Table 99: University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview
Table 100: Tissue-Engineered Vessel Graft - Product Status
Table 101: Tissue-Engineered Vessel Graft - Product Description
Table 102: ValveXchange, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 103: Vanguard System - Product Status
Table 104: Vanguard System - Product Description
Table 105: Vitality Exchangeable Valve System - Product Status
Table 106: Vitality Exchangeable Valve System - Product Description
Table 107: VXi Vanguard II - Product Status
Table 108: VXi Vanguard II - Product Description
Table 109: VueKlar Cardiovascular Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 110: MR-Enhancing Percutaneous Heart Valve - Product Status
Table 111: MR-Enhancing Percutaneous Heart Valve - Product Description
Table 112: Glossary

List of Figures
Figure 1: Tissue Heart Valves - Pipeline Products by Stage of Development
Figure 2: Tissue Heart Valves - Pipeline Products by Segment
Figure 3: Tissue Heart Valves - Pipeline Products by Territory
Figure 4: Tissue Heart Valves - Pipeline Products by Regulatory Path
Figure 5: Tissue Heart Valves - Pipeline Products by Estimated Approval Date
Figure 6: Tissue Heart Valves - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott Vascular Inc
  • Children's Hospital Boston
  • Colibri Heart Valve, LLC
  • CorMatrix Cardiovascular Inc
  • CryoLife Inc
  • Cytograft Tissue Engineering Inc
  • Daidalos Solutions BV
  • Edwards Lifesciences Corp
  • Medtronic plc
  • Revivicor Inc
  • Sree Chitra Tirunal Institute for Medical Sciences & Technology
  • Stellenbosch University
  • Tissue Regenix Ltd
  • University of California Irvine
  • University of Cambridge
  • University of Minnesota
  • ValveXchange, Inc.
  • VueKlar Cardiovascular Ltd
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll